Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$992,725,940
+$271,664,254 QoQ
Shares Held
8,657,242
0.0% QoQ
Ownership
10.4%
of shares outstanding
% of Portfolio
4.99%
of 13F equity value
Holder Rank
#2
of 273 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. KYMR ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
30,762,330 | $3,487,217,728 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,801,567 | $2,508,182,547 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
11,443,357 | $2,143,111,898 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,143,131 | $1,150,754,190 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
42,912,904 | $1,085,696,471 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
This page
|
8,657,242 | $992,725,940 | |
| 7 | INSM |
INSMED Inc
|
8,796,111 | $937,841,354 | |
| 8 | CELC |
Celcuity Inc.
|
7,915,792 | $828,150,159 |
All Filings in KYMR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $992,725,940 | 8,657,242 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $721,061,686 | 8,657,242 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $673,620,000 | 8,657,242 | Shares | Sole | 2026-02-17 | |
| 2025-12-09 | $753,840,123 | 8,676,797 | Shares | Sole | 2025-12-11 | |
| 2025-09-30 | $376,470,881 | 6,651,429 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $290,268,361 | 6,651,429 | Shares | Sole | 2025-08-14 | |
| 2025-06-26 | $304,727,543 | 6,666,540 | Shares | Sole | 2025-06-30 | |
| 2025-03-31 | $164,108,576 | 5,995,929 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $241,216,223 | 5,995,929 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $283,787,319 | 5,995,929 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $178,978,450 | 5,995,928 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $241,036,305 | 5,995,928 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $152,656,326 | 5,995,928 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $66,030,560 | 4,750,400 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $100,589,066 | 4,375,340 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $85,329,214 | 2,879,825 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $71,880,432 | 2,879,825 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $62,693,790 | 2,879,825 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $56,703,754 | 2,879,825 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $100,922,281 | 2,384,742 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $151,407,269 | 2,384,742 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $140,079,745 | 2,384,742 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $95,021,733 | 1,959,211 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $76,134,939 | 1,959,211 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $121,471,082 | 1,959,211 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $63,302,107 | 1,959,211 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||